Sleep changes during long-term treatment of depression with fluvoxamine - A home-based study

Psychopharmacology

Volumn 149, Issue 4, 2000, Pages 360-365

  Wilson, S J ^a   Bell, C ^a   Coupland, N J ^a,b   Nutt, D J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Antidepressant; Depression; Sleep; SSRIs

Indexed keywords

FLUVOXAMINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG SAFETY; FEMALE; HUMAN; LONG TERM CARE; MALE; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER; SLEEP PATTERN;

EID: 0034087535     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002139900362     Document Type: Article

References (34)

1. American Psychiatric Association (1987) Diagnostic and statistical manual, third edition (revised) (DSM IIIR). American Psychiatric Association, Washington, D.C.
2. Anderson IM, Deakin JFW, Miller HEJ (1996) The effect of chronic fluvoxamine on hormonal and psychological responses to buspirone in normal volunteers. Psychopharmacology 128: 74-82
3. Armitage R, Trivedi M, Hoffman R, Rush AJ (1997) Relationship between objective and subjective sleep measures in depressed patients and healthy controls. Depression Anxiety 5:97-102
4. Berger M, Emrich HM, Lund R, Lauer CJ, von Zerssen D (1986) Sleep-EEG variables as course criteria and predictors of antidepressant therapy with fluvoxamine/oxaprotaline. In: Hippius H, Matussek N (eds) Differential therapy of depression: possibilities and limitations, 2nd edn. Karger, New York, pp 110-120
5. Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15:220-226
6. Claassen V, Davies JE, Hertting G, Placheta P (1977) Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br J Pharmacol 60:505-516
7. Dominguez RA, Goldstein BJ, Jacobson AF, Steinbrook RM (1985) A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. J Clin Psychol 46:84-87
8. 1A agonist, on sleep patterns of healthy subjects. Psychopharmacology 117:186-192
9. Dunleavy DLF, Brezinova V, Oswald I, Maclean AW, Tinker M (1972) Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br J Psychiatry 120:663-672
10. Friston KJ, Sharpley AL, Solomon RA, Cowen PJ (1989) Lithium increases slow wave sleep: possible mediation by brain 5-HT-2 receptors. Psychopharmacology 98:139-140
11. Giles D, Jarrett RB, Roffwarg HP, Rush AJ (1987) Reduced rapid eye movement latency: a predictor of recurrence in depression. Neuropsychopharmacology 1:33-39
12. Gresham SC, Agnew HW, Williams RL (1965) The sleep of depressed patients. Arch Gen Psychiatry 13:503-507
13. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62
14. Hubain PP, Souery D, Jonck L, Staner L, Van Veeren C, Kerkhofs M, Mendlewitz J, Linkowski P (1995) Relationship between the Newcastle scale and sleep polysomnographic variables in major depression: a controlled study. Eur Neuropsychopharmacol 5:129-134
15. Idzikowski C, Cowen PJ, Nutt DJ, Mills FJ (1987) The effects of chronic ritanserin treatment on sleep and the neuroendocrine response to L-tryptophan. Psychopharmacology 93:416-420
16. Jones BE (1991) Paradoxical sleep and its chemical/structural substrates in the brain. Neuroscience 40:637-656
17. Katsuda Y, Walsh AES, Ware CJ, Cowen P, Sharpley AL (1993) meta-Chlorophenylpiperazine decreases slow wave sleep in humans. Biol Psychiatry 33:49-51
18. Kupfer DJ, Perel JM, Pollock BG, Nathan RS, Grochocinski VJ, Wilson MJ, McEachran AB (1991) Fluvoxamine versus desipramine: comparative polysomnographic effects. Biol Psychiatry 29:33-40
19. Kupfer DJ, Ehlers CL, Frank E, Grochocinski VJ, McEachran AB, Buhari A (1994) Persistent effects of antidepressants: EEG sleep studies in depressed patients during maintenance treatment. Biol Psychiatry 35:781-793
20. Lauer CJ, Riemann D, Wiegand M, Berger M (1991) From early to late adulthood: changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry 29:979-993
21. Lauer CJ, Schreiber W, Holsboer F, Krieg JC (1995) In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry 52:145-152
22. Massou JM, Trichard C, Attar-Levy D, Feline A, Corruble E, Beaufils B, Martinot JL (1997) Frontal 5HT(2A) receptors studied in depressive patients during chronic treatment by selective serotonin reuptake inhibitors. Psychopharmacology 133: 99-101
23. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. US Department of HEW, Washington, D.C.
24. Reynolds CF, Kupfer DJ (1987) Sleep research in affective illness. Sleep 10:199-215
25. Reynolds CF, Hoch CC, Buysse DJ, George CJ, Houck PR, Mazumdar S, Miller M, Pollock BG, Rifai H, Frank E, Cornes C, Morycz RK, Kupfer DJ (1991) Sleep in late-life recurrent depression: changes during early continuation therapy with nortriptyline. Neuropsychopharmacology 5:85-96
26. Rush AJ, Armitage R, Gillin JC, Yonkers KA, Winokur A, Moldofsky H, Vogel GW, Kaplita S, Fleming JB, Montplaisir J, Erman MK, Albala B, McQuade RD (1998) Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry 44:3-14
27. Sharpley AL, Cowen PJ (1995) Effect of pharmacologic treatments on the sleep of depressed patients. Biol Psychiatry 37: 84-98
28. Sharpley AL, Solomon RA, Cowen PJ (1988) Evaluation of first night effect using ambulatory monitoring and automatic sleep stage analysis. Sleep 11:273-276
29. 2 receptor antagonists on slow wave sleep in humans. Psychopharmacology 101:568-569
30. Sharpley AL, Williams DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ (1996) The effects of paroxetine and nefazodone on sleep; a placebo-controlled trial. Psychopharmacology 126: 50-54
31. Trivedi MH, Rush J, Armitage R, Gullion CM, Orsulak PJ, Roffwarg HP (1999) Effects of fluoxetine on the polysomnogram in outpatients with major depression. Neuropsychopharmacology 20:447-459
32. van Bemmel AL, van den Hoofdakker RH, Beersma DGM, Bouhuys AL (1993) Changes in sleep polygraphic variables and clinical state in depressed patients during treatment with citalopram. Psychopharmacology 113:225-230
33. Vogel GW, Buffenstein A, Minter K, Hennessey A (1990) Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Rev 14:49-63
34. Wilson SJ, Bailey JE, Ashford JJ, Alford C, Coupland NJ, Nutt DJ (1994) Effects of fluvoxamine and dothiepin on sleep and daytime sleepiness in normal volunteers. J Psychopharmacol 8:A9